Local implantation of doxorubicin drug eluting beads in rat glioma

International Journal of Pharmaceutics

Volumn 402, Issue 1-2, 2010, Pages 184-189

  Vinchon Petit, S ^a,b   Jarnet, D ^b   Michalak, S ^c   Lewis, A ^d   Benoit, J P ^a   Menei, P ^a,c  

^a UNIVERSITÉ D'ANGERS   (France)

^b CENTRE PAUL PAPIN   (France)

^c ANGERS UNIVERSITY HOSPITAL   (France)

^d BIOCOMPATIBLES UK LTD   (United Kingdom)

Author keywords

Concomitant therapy; DC beads; Doxorubicin; Glioma; Local chemotherapy; Radiotherapy

Indexed keywords

DOXORUBICIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOCOMPATIBILITY; BRAIN RADIATION; CANCER TRANSPLANTATION; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; DRUG ELUTING BEAD; DRUG IMPLANT; DRUG IMPLANTATION; DRUG SAFETY; FEMALE; GLIOMA; IMMUNOHISTOCHEMISTRY; INJECTION; KAPLAN MEIER METHOD; LOCAL THERAPY; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL TIME; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; BRAIN NEOPLASMS; CELL LINE, TUMOR; COMBINED MODALITY THERAPY; DOSE-RESPONSE RELATIONSHIP, DRUG; DOXORUBICIN; DRUG IMPLANTS; FEMALE; GLIOMA; RATS; RATS, INBRED F344; RATS, WISTAR; SURVIVAL; TIME FACTORS;

EID: 78349311804     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2010.09.013     Document Type: Article

References (41)

1. Aliberti C., Tilli M., Benea G., Fiorentini G. Trans-arterial chemoembolization (TACE) of liver metastases from colorectal cancer suing irinotecan-eluting beads: preliminar results. Anticancer Res. 2006, 26:3793-3795.
2. Aliberti C., Benea G., Tilli M., Fiorentini G. Chemoembolization (TACE) of unresectable intrahepatic cholangiocarcinoma with slow-release doxorubicin-eluting beads: preliminary results. Cardiovasc. Intervent. Radiol. 2008, 31:883-888.
3. Bartoli M.H., Boitard M., Fessi H., Beriel H., Devissaguet J.P., Picot F., Puisieux F. In vitro and in vivo antitumoral activity of free and encapsulated taxol. J. Microencapsul. 1990, 7:191-197.
4. Bauchet L., Rigau V., Mathieu-Daudé H., Figarella-Branger D., Hugues D., Palusseau L., Bauchet F., Fabbro M., Campello C., Capelle L., Durand A., Trétarre B., Frappaz D., Henin D., Menei P., Honnorat J., Segnarbieux F. French brain tumor data bank: methodology and first results on 10000 cases. J. Neurooncol. 2007, 84:189-199.
5. Blates S., Freund I., Lewis A.L., Nolte I., Brinker T. Doxorubicin and irinotecan drug-eluting beads for treatment of glioma: a pilot study in a rat model. J. Mater. Sci. Mater. Med. 2010, 21:1393-1402.
6. Brem H., Piantadosi S., Burger P.C., Walker M., Selker R., Vick N.A., Black K., Sisti M., Brem S., Mohr G., Muller P., Morawetz R., Schold S.C. Placebo-controlled trial of safety and efficacy of intraoperative controlled delivery by biodegradable polymers of chemotherapy for recurrent gliomas. Lancet 1995, 345:1008-1012. for the Polymer-Brain Tumor Treatment Group.
7. Buie L.W., Valgus J.M. Bevacizumab: a treatment option for recurrent glioblastoma multiforme. Ann. Pharmacother. 2008, 42:1486-1490.
8. de Baere T., Deschamps F., Teriitheau C., Rao P., Conengrapht K., Schlumberger M., Leboulleux S., Baudin E., Hechellhammer L. Transarterial chemoembolization of liver metastases from well differentiated gastroenteropancreatic endocrine tumors with doxorubicin-eluting beads: preliminary results. J. Vasc. Interv. Radiol. 2008, 19:855-861.
9. Eyol E., Boleij A., Taylor R.R., Lewis A.L., Berger M.R. Chemoembolisation of rat colorectal liver metastases with drug eluting beads loaded with irinotecan or doxorubicin. Clin. Exp. Metastasis 2008, 25:273-282.
10. Fiorentini G., Aliberti C., Turrisi G., Del Conte A., Rossi S., Benea G., Giovanis P. Intraarterial hepatic chemoembolization of liver metastases from colorectal cancer adopting irinotecan-eluting beads: results of a phase II clinical study. In Vivo 2007, 21:1085-1091.
11. Forster, R.E.J., Small, S.A., Tang, Y., Heasysman, C.L., Lloyd, A.W., MacFarlane, W., Phillips, G.J., Antonijevic, M.D., Lewis, A.L., in press. Comparison of DC Bead-irinotecan and DC Bead-topotecan drug eluting beads for use in locoregional drug delivery to treat pancreatic cancer, J. Mater. Sci. Mater. Med.
12. Gonzalez M.V., Tang Y., Phillips G.J., Lloyd A.W., Hall B., Stratford P.W., Lewis A.L. Doxorubicin eluting beads-2: methods for evaluating drug elution and in-vitro: in-vivo correlation. J. Mater. Sci. Mater. Med. 2008, 19:767-775.
13. Hong K., Khwaja A., Liapi E., Torbenson M.S., Georgiades C.S., Geschwind J.F. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer. Clin. Cancer Res. 2006, 12(8 (April)):2563-2567.
14. Keese M., Gasimova L., Schwenke K., Yagublu V., Shang E., Faissner R., Lewis A., Samel S., Löhr M. Doxorubicin and mitoxantrone drug eluting beads for the treatment of experimental peritoneal carcinomatosis in colorectal cancer. Int. J. Cancer 2009, 124:2701-2708.
15. Krauze M.T., Noble C.O., Kawaguchi T., Drummond D., Kirpotin D.B., Yamashita Y., Kullberg E., Forsayeth J., Park J.W., Bankiewicz K.S. Convection-enhanced delivery of nanoliposomal CPT-11 (irinotecan) and PEGylatedliposomal doxorubicin (Doxil) in rodent intracranial brain tumor xenografts. Neuro. Oncol. 2007, 9:393-403.
16. Kubo O., Himuro H., Inoue N., Tajika Y., Tajika T., Tohyama T., Skairi M., Yoshida M., Kaetsu I., Kitamura K. Treatment of malignant brain tumors with slowly releasing anticancer drug-polymer composites. No Shinkei Geka. 1986, 14:1189-1195.
17. Lammer J., Malagari K., Vogl T., Pilleul F., Denys A., Watkinson A., Pitton M., Sergent G., Pfammatter T., Terraz S., Benhamou Y., Avajon Y., Gruenberger T., Pomoni M., Langenberger H., Schuchmann M., Dumortier J., Mueller C., Chevallier P., Lencioni R. Prospective randomized study of doxorubicin-eluting-bead embolization in the treatment of hepatocellular carcinoma: results of the PRECISION V study. Cardiovasc. Intervent. Radiol. 2010, 33:41-52. PRECISION V Investigators.
18. Lencioni R., Crocetti L., Petruzzi P., Vignali C., Bozzi E., Della Pina C., Bargellini I., Cioni D., Oliveri F., De Simone P., Bartolozzi C., Brunetto M., Filipponi F. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study. J. Hepatol. 2008, 49:217-222.
19. Lesniak M.S., Upadhyay U., Goodwin R., Tyler B., Brem H. Local delivery of doxorubicin for the treatment of malignant brain tumors in rats. Anticancer Res. 2005, 25:3825-3831.
20. Lewis A.L., Gonzalez M.V., Lloyd A.W., Hall B., Tang Y., Willis S.L., Leppard S.W., Wolfenden L.C., Palmer R.R., Stratford P.W. DC Bead: in vitro characterization of a drug-delivery device for transarterial chemoembolization. J. Vasc. Interv. Radiol. 2006, 17:335-342.
21. Lewis A.L., Taylor R.R., Hall B., Gonzalez M.V., Willis S.L., Stratford P.W. Pharmacokinetic and safety study of doxorubicin-eluting beads in a porcine model of hepatic arterial embolization. J. Vasc. Interv. Radiol. 2006, 17:1335-1343.
22. Lewis A.L., Gonzalez M.V., Leppard S.W., Brown J.E., Stratford P.W., Phillips G.J., Lloyd A.W. Doxorubicin eluting beads-1: effects of drug loading on bead characteristics and drug distribution. J. Mater. Sci. Mater. Med. 2007, 18:1691-1699.
23. Lewis A.L. DC Bead: a major development in the toolbox for the interventional oncologist. Expert Rev. Med. Devices 2009, 6:389-400.
24. Malagari K., Chatzimichael K., Alexopoulou E., Kelekis A., Hall B., Dourakis S., Delis S., Gouliamos A., Kelekis D. Transarterial chemoembolization of unresectable hepatocellular carcinoma with drug eluting beads: results of an open-label study of 62 patients. Cardiovasc. Intervent. Radiol. 2008, 31:269-280.
25. Menei P., Boisdron-Celle M., Croué A., Guy G., Benoit J.P. Effect of stereotactic implantation of biodegradable 5-fluorouracil-loaded microspheres in healthy and C6 glioma-bearing rats. Neurosurgery 1996, 39:117-123. (discussion 123-124).
26. Menei P., Jadaud E., Faisant N., Boisdron-Celle M., Michalak S., Fournier D., Delhaye M., Benoit J.P. Stereotaxic implantation of 5-FU releasing microspheres in malignant glioma: phase I study. Cancer 2004, 100:405-410.
27. Menei P., Capelle L., Guyotat J., Fuentes S., Assaker R., Bataille B., François P., Dorwling-Carter D., Paquis P., Bauchet L., Parker F., Sabatier J., Faisant N., Benoit J.P. Local and sustained delivery of 5-fluorouracil from biodegradable microspheres for the radiosensitization of malignant glioma: a randomized phase II trial. Neurosurgery 2005, 56:242-248.
28. Menei P., Montero-Menei C., Venier M.C., Benoit J.P. Drug delivery into the brain using poly (lactide-co-glycolide) microspheres. Expert Opin. Drug Deliv. 2005, 2:363-376.
29. Mu L., Feng S.S. PLGA/TPGS nanoparticles for controlled release of paclitaxel: effects of the emulsifier and drug loading ratio. Pharm. Res. 2003, 20:1864-1872.
30. Namur J., Wassef M., Millot J.M., Lewis A.L., Manfait M., Laurent A. Drug-eluting beads for liver embolization: concentration of doxorubicin in tissue and in beads in a pig model. J. Vasc. Interv. Radiol. 2010, 21:259-267.
31. Oda Y., Tokuriki Y., Tsuda E., Handa H., Kieler J. Treatment of brain tumors with anticancer pellet. Experimental and clinical study. No Shinkei Geka. 1982, 10:375-381.
32. Poon R.T., Tso W.K., Pang R.W., Ng K.K., Woo R., Tai K.S., Fan S.T. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead. Clin. Gastroenterol. Hepatol. 2007, 5:1100-1108.
33. Rousseau J., Barth R.F., Fernandez M., Adam J.F., Balosso J., Estève F., Elleaume H. Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors. J. Neurooncol. 2009, 11.
34. Sapin A., Clavreul A., Garcion E., Benoit J.P., Menei P. Evaluation of particulate systems supporting tumor cell fractions in a preventive vaccination against intracranial rat glioma. J. Neurosurg. 2006, 105:745-752.
35. Stan A.C., Casares S., Radu D., Walter G.F., Brumeanu T.D. Doxorubicin-induced cell death in highly invasive human gliomas. Anticancer Res. 1999, 19:941-950.
36. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 2005, 352:987-996.
37. Tang Y., Czuczman P.R., Chung S.T., Lewis A.L. Preservation of the active lactone form of irinotecan using drug eluting beads for the treatment of colorectal cancer metastases. J. Control. Release 2008, 127:70-78.
38. Valtonen S., Timonen U., Toivanen P., Kalimo H., Kivipelto L., Heiskanen O., Unsgaard G., Kuurne T. Interstitial chemotherapy with carmustine-loaded polymers for high-grade gliomas: a randomized double-blind study. Neurosurgery 1997, 41:44-48.
39. Vauthier C., Dubernet C., Chauvierre C., Brigger I., Couvreur P. Drug delivery to resistant tumors: the potential of poly (alkylcyanoacrylate) nanoparticles. J. Control. Release 2003, 93:151-160.
40. Westphal M., Hilt D.C., Bortey E., Delavault P., Olivares R., Warnke P.C., Whittle I.R., Jääskeläinen J., Ram Z.A. A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro. Oncol. 2003, 5:79-88.
41. Westphal M., Ram Z., Riddle V., Hilt D., Bortey E. Gliadel wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial. Acta Neurochir. 2006, 148:269-275.